Swiss Longitudinal Cohort

Hypertension Excellence Centre Lucerne

Status: Enrolling

Conditions: Cardiovascular Risk Factors

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT02282748

SNCTP 000000612

Details and patient eligibility

About

The planned research project is a prospective population-based cohort study, similar to the well-known Framingham study in the United States. So far, there is no similar research project in Switzerland.

It is planned to examine of three Swiss municipalities. Recruitment in a first Swiss municipality (Lostallo/Cama GR) started 2014 and ended in 2019. Overall, 496 participants were recruited in this municipality. The five-year follow-up in this municipality started in 2019. It is planned to start recruitment in a second Swiss municipality (Uznach SG) in 2020.

The examinations embrace a broad spectrum of measurements (for details the investigators refer to the published study protocol).

Enrollment: 1,000 estimated patients

Sex: All

Ages: 6+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Resident of Cama GR, Lostallo GR, or Uznach SG
• Age ≥6 years (no upper age limit), for voluntary blood sample ≥18 years
• Willing to participate in long-term study
• Written informed consent (in participants ≥6 years and <18 years signed by parents)

Exclusion criteria

• No exclusion criteria